A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.

A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.

Item
http://www.wikidata.org/entity/Q33404541
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer.Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaDasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan, and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expression.Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cellsBiomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?[Research status of molecular targeted therapy in thymic epithelial tumors].
P2860

A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.

Item
http://www.wikidata.org/entity/Q33404541
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A phase 1 study of gemcitabine ...... ts with advanced solid tumors.
@ast
A phase 1 study of gemcitabine ...... ts with advanced solid tumors.
@en
type
label
A phase 1 study of gemcitabine ...... ts with advanced solid tumors.
@ast
A phase 1 study of gemcitabine ...... ts with advanced solid tumors.
@en
prefLabel
A phase 1 study of gemcitabine ...... ts with advanced solid tumors.
@ast
A phase 1 study of gemcitabine ...... ts with advanced solid tumors.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P932
P356
P1433
P1476
A phase 1 study of gemcitabine ...... ts with advanced solid tumors.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P932